β-2 Agonists as Misusing Drugs? Assessment of both Clenbuterol- and Salbutamol-related European Medicines Agency Pharmacovigilance Database Reports

The use of supplements and performance and image enhancing drugs in fitness settings: A exploratory cross-sectional investigation in the United Kingdom

(2017) Roisin Mooney et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency’s ‘Suspected Adverse Drug Reactions’ Database

(2016) Stefania Chiappini et al.   CNS DRUGS

Rhabdomyolysis Secondary to Clenbuterol Use and Exercise

(2016) Nicole M. Grimmer et al.   JOURNAL OF EMERGENCY MEDICINE

Drogas potenciadoras para la búsqueda de la perfección

(2016) Jim McVeigh et al.   Adicciones

Profiling online recreational/prescription drugs' customers and overview of drug vending virtual marketplaces

(2015) Laura Orsolini et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Use and abuse of medication during 2014 FIFA World Cup Brazil: a retrospective survey

(2015) Martin Vaso et al.   BMJ Open

Adverse Psychiatric Effects Associated with Herbal Weight-Loss Products

(2015) F. Saverio Bersani et al.   Biomed Research International

Impact of Ethnicity, Gender, and Dehydration on the Urinary Excretion of Inhaled Salbutamol With Respect to Doping Control

(2014) John Dickinson et al.   CLINICAL JOURNAL OF SPORT MEDICINE

Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement

(2014) Harrison G. Pope et al.   ENDOCRINE REVIEWS

Clenbuterol toxicity: a NSW Poisons Information Centre experience

(2014) Jonathan Brett et al.   MEDICAL JOURNAL OF AUSTRALIA

Prevalence and Correlates of Anabolic–Androgenic Steroid Use in a Nationally Representative Sample of 17-Year-Old Norwegian Adolescents

(2014) Dominic Sagoe et al.   SUBSTANCE USE & MISUSE

The diffusion of Performance and Image-Enhancing Drugs (PIEDs) on the Internet: The Abuse of the Cognitive Enhancer Piracetam

(2014) Ornella Corazza et al.   SUBSTANCE USE & MISUSE

2012 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 30th Annual Report

(2013) James B. Mowry et al.   CLINICAL TOXICOLOGY

The Adverse Health Consequences of the Use of Multiple Performance-Enhancing Substances—A Deadly Cocktail

(2013) Nimalie J. Perera et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Doping Control Using High and Ultra-High Resolution Mass Spectrometry Based Non-Targeted Metabolomics-A Case Study of Salbutamol and Budesonide Abuse

(2013) Agneta Kiss et al.   PLoS One

A Descriptive Study of Adverse Events from Clenbuterol Misuse and Abuse for Weight Loss and Bodybuilding

(2013) Henry A. Spiller et al.   Substance Abuse

Quantification of clenbuterol at trace level in human urine by ultra-high pressure liquid chromatography–tandem mass spectrometry

(2012) Raul Nicoli et al.   JOURNAL OF CHROMATOGRAPHY A

Myocardial Ischemia Associated with Clenbuterol Abuse: Report of Two Cases

(2012) David S. Huckins et al.   JOURNAL OF EMERGENCY MEDICINE

Muscle-enhancing Behaviors Among Adolescent Girls and Boys

(2012) M. E. Eisenberg et al.   PEDIATRICS

Salbutamol misuse or abuse with fatal outcome: A case-report

(2010) Alexandra Boucher et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Acute myocardial infarction due to coronary vasospasm and salbutamol abuse

(2009) S Ferrua et al.   HEART

Atrial fibrillation associated with chocolate intake abuse and chronic salbutamol inhalation abuse

(2009) Salvatore Patanè et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Missbrauch von anabolen androgenen Steroiden

(2008) S. Lüderwald et al.   Rechtsmedizin

Clenbuterol marketed as dietary supplement

(2007) Maria K. Parr et al.   BIOMEDICAL CHROMATOGRAPHY